| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 1-6 months |
| Number of Subjects | 34 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Average |
Treatment of 5.4g Reishi polysaccharides daily for 12 weeks in advanced cancer patients was able to improve parameters of immunity (CD56+ cell count; no influence on CD4:CD8 ratio) and natural killer cell activity while suppressing TNF-a and IL-1 levels.
Responses to Phytohaemagglutinin were significantly improved, with NK cell activity increasing to 34.5 +/- 11.8% of baseline (placebo 26.6 +/- 8.3%)
